If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInspiration Hlt Regulatory News (IHC)

Share Price Information for Inspiration Hlt (IHC)

Share Price is delayed by 15 minutes
Get Live Data
19.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.00 (5.263%)
Market Cap: £17.48m
IHC Live PriceLast checked at - London Stock Exchange

Intraday Inspiration Hlt Share Chart

Directorate Change

28 Jan 2025 07:00

RNS Number : 8562U
Inspiration Healthcare Group PLC
28 January 2025
 

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

 

Board changes

 

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company pioneering best-in-class, specialist neonatal intensive care medical devices, announces the retirement of Bob Beveridge, Non-Executive Director ("NED") who is stepping down after nine years in line with best practice. Bob will be replaced as NED and Chair of the Audit Committee by Richard Jones. The Board wish to thank Bob for his years of service and commitment to Inspiration Healthcare during his tenure and are delighted to be able to appoint Richard to the role. Both changes will come into effect from 31 January 2025.

 

Richard is a seasoned healthcare and life sciences professional with extensive experience as a board member of publicly listed companies. He has spent more than 20 years serving in both independent NED and Executive Director roles and has acted as a key adviser across a diverse range of public and private companies in the life sciences space. He has expertise across a wide spectrum of Board issues and has worked extensively outside the UK PLC market having completed a US reverse merger as CFO for a UK biotech company in 2019.

 

Currently he is a Senior Independent Director and Audit Committee Chair of Alliance Pharma PLC, an AIM listed international consumer healthcare company where he is closely involved in all aspects of the business. Formerly, he was Chief Financial Officer ("CFO") and Company Secretary of the UK and Ireland's leading supplier of tele-radiology services, Medica Group Ltd. His CFO and Board experience also includes Mereo Biopharma PLC and Shield Therapeutics PLC.

 

Roy Davis, Executive Chairman of Inspiration Healthcare said: "We are delighted to welcome Richard on board, and we are excited to be able to tap into his extensive capital markets experience, as well as his in-depth knowledge of the US market where we continue to grow our presence.

 

"On behalf of the Board, I would like to thank Bob for his dedication and commitment to Inspiration Healthcare over almost a decade. We will be sad to see him go, and we wish him all the very best for his future plans."

 

Bob Beveridge, outgoing Non-Executive Director said: "I have thoroughly enjoyed my time with the Inspiration Healthcare team over the years. I believe they are at a key transitional phase, and I know they will be a great success. I wish them well for a bright future."

 

Richard Jones, incoming Non-Executive Director added: "I am looking forward to joining the Board of Inspiration Healthcare and sharing my PLC and life sciences industry expertise with the team."

 

In accordance with Schedule 2 (g) of the AIM Rules for Companies, Richard Crispin Morgan Jones (aged 58 years) holds / has held the following directorships/partnerships in the last five years:

 

Current directorships / partnerships

Previous directorships / partnerships in last 5 years

Alliance Pharma plc

Global Diagnostics Ireland Ltd

C4X Discovery Holdings Limited

Global Retinopathy Screening Ltd

Hampshire Topco Limited

JCA Seminars Limited

Hero Acquisitions Limited

Medica Australia Pty Ltd

HSS Hire Group plc

Medica Group Limited

HSS Hire Service Finance Limited

Medica IT Services Limited

RCMJ Consultancy Ltd

Medica Reporting Finance Limited

Medica Reporting Limited

Medica Reporting Services Limited

Medica US Inc

Med-IDX Pty Ltd

Med-IDX UK Limited

Mereo Biopharma 1 Limited

Mereo Biopharma 2 Limited

Mereo Biopharma 3 Limited

Mereo Biopharma 4 Limited

Mereo Biopharma Group plc

Mereo BioPharma Ireland Limited

Mereo MereoCo Inc

Mereo US Holdings Inc

Moonlight Bidco Limited

Moonlight Midco 1 Limited

Moonlight Midco 2 Limited

Moonlight Topco Limited

 

Richard Crispin Morgan Jones does not hold any ordinary shares in the capital of the Company. There are no further disclosures to be made in accordance with AIM Rule 17 or Schedule 2(g) of the AIM Rules for Companies.

 

For further information, please contact:

 

Inspiration Healthcare Group plc

Tel: +44 (0)330 175 0000

Roy Davis, Executive Chair

Alan Olby, Chief Financial Officer

Panmure Liberum (Nominated Adviser & Broker)

Tel: +44 (0)20 3100 2000

Richard Lindley

Will King

 

Walbrook PR Ltd (Media and Investor Relations)

Tel: +44 (0)20 7933 8780 or inspirationhealthcare@walbrookpr.com

Anna Dunphy

Mob: +44 (0) 7876 741 001

Louis Ashe-Jepson

Mob: +44 (0) 7747 515 393

 

About Inspiration Healthcare

 

Inspiration Healthcare (AIM: IHC) designs, manufactures and markets pioneering medical technology. Based in the UK, the Company specialises in neonatal intensive care medical devices, which are addressing a critical need to help to save the lives and improve the outcomes of patients, starting with the very first breaths of life.

 

The Company has a broad portfolio of its own products and complementary distributed products, for use in neonatal intensive care designed to support even the most premature babies throughout their hospital stay. Its own branded products range from highly sophisticated capital equipment such as ventilators for life support through to single-use disposables.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABRGDBLUDDGUR
Date   Source Headline
21st Jan 20207:00 amRNSEC certificates extended to May 2024
20th Jan 20207:00 amRNSSri Lankan Ministry of Health Order
9th Jan 202012:55 pmRNSTR1 Notification
7th Jan 20201:01 pmRNSTR1 Notification
31st Dec 20197:00 amRNSNPXe Files Chapter 11 to implement Asset Sale
30th Oct 20197:00 amRNSCosyTherm2 Launch and Investor Conference
2nd Oct 20197:00 amRNSInterim Results
26th Sep 201910:35 amRNSHolding(s) in Company
26th Sep 201910:32 amRNSHolding(s) in Company
25th Sep 20193:27 pmRNSHolding(s) in Company
24th Sep 20191:33 pmRNSHolding(s) in Company
24th Sep 201910:20 amRNSHolding(s) in Company
24th Sep 201910:17 amRNSHolding(s) in Company
24th Sep 201910:14 amRNSHolding(s) in Company
24th Sep 201910:11 amRNSHolding(s) in Company
24th Sep 201910:09 amRNSDirector/PDMR Shareholding
23rd Sep 20193:42 pmRNSResult of General Meeting
12th Sep 20197:00 amRNSNotice of Interim Results
5th Sep 20197:00 amRNSProposed Acquisition of Vio Holdings and Placing
15th Aug 20197:00 amRNSTrading Update
27th Jun 20191:16 pmRNSResult of AGM
27th Jun 20197:00 amRNSAGM Statement
28th May 20197:00 amRNSUpdate regarding NPXe plc
23rd May 20197:00 amRNSNotice of AGM
30th Apr 20197:00 amRNSPreliminary Results
23rd Apr 20197:00 amRNSWinning of Queen's Award for Enterprise
20th Mar 20197:00 amRNSCertification received to the new MDSAP
14th Mar 20197:00 amRNSLargest Ever Patient Warming System Order
22nd Feb 20197:00 amRNSTrading Update and Notice of Results
11th Feb 201911:01 amRNSPrice Monitoring Extension
25th Jan 20197:00 amRNSGrowth & Innovation Forum 2019
18th Dec 20187:00 amRNSLicensing agreement with US University
7th Dec 20187:00 amRNSStatement re potential IPO of NeuroproteXeon
8th Nov 20187:00 amRNSGrant of Options
2nd Oct 20187:00 amRNSInterim Results
30th Aug 20187:00 amRNSInvestor Evening - 4 October 2018
24th Aug 20187:00 amRNSTrading Update and Notice of Results
3rd Jul 20187:00 amRNSRenewal of Tecotherm and Micrel Agreements
15th Jun 201812:30 pmRNSResult of AGM
15th Jun 20187:00 amRNSAGM Statement
7th Jun 20187:00 amRNSPotential IPO of NeuroproteXeon Limited
18th May 201811:59 amRNSPosting of Annual Report and Notice of AGM
9th May 20183:15 pmRNSNeuroproteXeon and Linde Distribution Partnership
24th Apr 20187:00 amRNSPreliminary Results
21st Feb 20187:00 amRNSTrading Update
18th Jan 20187:00 amRNSCFM unit granted CE mark and Neotech Agreement.
9th Jan 20187:00 amRNSAppointment of Head of Marketing
14th Nov 20177:00 amRNSEnhanced LifeStart launched at MEDICA
9th Nov 20177:00 amRNSGrant of Options
17th Oct 20179:15 amRNSCorrected rPAP Driver Unit Granted CE mark notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.